ConcertAI
Enterprise AI and real-world data SaaS solutions for life sciences and healthcare clinical research.
About
ConcertAI offers generative and agentic AI solutions tailored for life sciences and healthcare products, focusing on regulatory, research, commercial, and clinical development needs. Their platform leverages real-world data to provide precision insights, accelerate clinical trials, and support regulatory-grade evidence and commercial outcomes. Key offerings include the Precision Suite, Commercial Solutions, Clinical Development tools, CancerLinQ, and TeraRecon for advanced medical imaging. Teams look it up for AI, SaaS, HealthTech.
Frequently asked
What does ConcertAI do?
ConcertAI is an AI company that offers Platform. Teams look it up for SaaS, HealthTech, Life Sciences. It is based in Cambridge, United States and was founded in 2018. Public records show $300M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has ConcertAI raised?
ConcertAI has raised a total of $300M in funding. The most recent round on record is Series C.
Where is ConcertAI headquartered?
ConcertAI is headquartered in Cambridge, United States.
When was ConcertAI founded?
ConcertAI was founded in 2018.
What industry does ConcertAI operate in?
ConcertAI operates in AI, SaaS, HealthTech, Life Sciences, Agentic AI.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.